{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:19:50Z","timestamp":1790698790117,"version":"4.1.0"},"reference-count":60,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2010,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1111\/j.1529-8019.2010.01310.x","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T16:22:31Z","timestamp":1269534151000},"page":"155-159","source":"Crossref","is-referenced-by-count":29,"title":["Psoriasis, the liver, and the gastrointestinal tract"],"prefix":"10.1155","volume":"23","author":[{"given":"Paolo","family":"Gisondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol","family":"Del Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1503\/cmaj.045232","article-title":"Nonalcoholic fatty liver disease","volume":"172","author":"Adams","year":"2005","journal-title":"CMAJ"},{"issue":"1","key":"10.1111\/j.1529-8019.2010.01310.x-BIB2","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Non-alcoholic fatty liver disease: the mist gradually clears","volume":"48","author":"de Alwis","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.numecd.2007.01.007","article-title":"Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question","volume":"17","author":"Loria","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB4","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","article-title":"Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Gisondi","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","article-title":"Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Miele","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB9","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2265.2006.02527.x","article-title":"Associations between plasma adiponectin concentrations and liver histology in patients with non-alcoholic fatty liver disease","volume":"64","author":"Targher","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jhep.2006.09.005","article-title":"Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease","volume":"45","author":"Targher","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/oby.2008.64","article-title":"NASH predicts plasma inflammatory biomarkers independently of visceral fat in men","volume":"16","author":"Targher","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1478-3231.2005.01191.x","article-title":"Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis","volume":"26","author":"Abiru","year":"2006","journal-title":"Liver Int"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB16","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1572-0241.2004.30159.x","article-title":"Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with non-alcoholic steatohepatitis","volume":"99","author":"Chalasani","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB17","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3748\/wjg.14.1972","article-title":"Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy","volume":"14","author":"Torres","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB18","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB19","first-page":"787","article-title":"Increased occurrence of psoriasis in patients with Crohn's disease and their relatives","volume":"86","author":"Hoffmann","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM198301133080213","article-title":"Crohn's disease and psoriasis","volume":"308","author":"Hughes","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1067\/mjd.2003.540","article-title":"Connections between psoriasis and Crohn's disease","volume":"48","author":"Najarian","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB22","first-page":"206","article-title":"Psoriasis and Crohn's disease","volume":"66","author":"Rudikoff","year":"1999","journal-title":"Mt Sinai J Med"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB23","first-page":"962","article-title":"Increased occurrence of psoriasis in patients with Crohn's disease and their relatives","volume":"85","author":"Lee","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1468-3083.2008.03031.x","article-title":"Psoriasis associated with ulcerative colitis and Crohn's disease","volume":"23","author":"Cohen","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2133.1982.tb01731.x","article-title":"Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis","volume":"106","author":"Yates","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/gut.44.4.519","article-title":"Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses","volume":"44","author":"Yang","year":"1999","journal-title":"Gut"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB27","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/hmg\/6.8.1349","article-title":"Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan","volume":"6","author":"Nair","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/379821a0","article-title":"Mapping of a susceptibility locus for Crohn's disease on chromosome 16","volume":"379","author":"Hugot","year":"1996","journal-title":"Nature"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in the NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1086\/302294","article-title":"A genome-wide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort","volume":"64","author":"Hampe","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1523-1747.2002.01749.x","article-title":"Searching for the major histocompatibility complex psoriasis susceptibility gene","volume":"118","author":"Capon","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.ejhg.5200365","article-title":"Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden","volume":"7","author":"Enlund","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ng1096-231","article-title":"Evidence that a locus for familial psoriasis maps to chromosome 4q","volume":"14","author":"Matthews","year":"1996","journal-title":"Nat Genet"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB35","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1073\/pnas.95.13.7502","article-title":"Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1","volume":"95","author":"Cho","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng1096-199","article-title":"Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7, and 12","volume":"14","author":"Satsangi","year":"1996","journal-title":"Nat Genet"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jmg.2007.053595","article-title":"Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease","volume":"45","author":"Wolf","year":"2008","journal-title":"J Med Genet"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00439-007-0397-0","article-title":"Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis","volume":"122","author":"Capon","year":"2007","journal-title":"Hum Genet"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL 12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB40","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immun Rev"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/09546630802206660","article-title":"Th17 cells: a new therapeutic target in inflammatory dermatoses","volume":"19","author":"Asarch","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB43","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB44","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.3748\/wjg.v12.i41.6585","article-title":"Celiac disease","volume":"12","author":"Rodrigo","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB45","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1053\/j.gastro.2006.10.004","article-title":"American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease","volume":"131","author":"Rostom","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB46","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1572-0241.2001.03753.x","article-title":"The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus","volume":"96","author":"Rensch","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB47","first-page":"603","article-title":"Gliadin immunoreactivity in patients with rheumatoid arthritis","volume":"13","author":"Paimela","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB48","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.1999.01011.x","article-title":"Celiac disease and markers of celiac disease latency in patients with primary Sjogren's syndrome","volume":"94","author":"Iltanen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2133.2000.03240.x","article-title":"Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet","volume":"142","author":"Michaelsson","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2133.2002.47947.x","article-title":"Is the search for serum antibodies to gliadin, endomysium and tissue transglutaminase meaningful in psoriatic patients? Relationship between the pathogenesis of psoriasis and coeliac disease","volume":"147","author":"Cardinali","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/rheumatology\/41.1.31","article-title":"IgA antibodies to gliadin and celiac disease in psoriatic arthritis","volume":"41","author":"Lindqvist","year":"2002","journal-title":"Rheumatology"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB52","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1468-3083.2008.02713.x","article-title":"Serologic markers of celiac disease in psoriatic patients","volume":"22","author":"Damasiewicz-Bodzek","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB53","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1365-2133.2004.06137.x","article-title":"Coeliac disease-associated antibodies correlate with psoriasis activity","volume":"151","author":"Woo","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB54","first-page":"2574","article-title":"High prevalence of celiac disease in psoriasis. Am","volume":"98","author":"Ojetti","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB55","first-page":"1296","article-title":"Frequency of celiac disease among patients with psoriasis","volume":"135","author":"Calder\u00f3n","year":"2007","journal-title":"Rev Med Chil"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB56","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1365-2133.2005.06636.x","article-title":"Association between psoriasis and coeliac disease","volume":"152","author":"Abenavoli","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB57","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1365-2133.2009.09398.x","article-title":"Coeliac disease associated with psoriasis","volume":"161","author":"Birkenfeld","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB58","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/jid.2008.40","article-title":"Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis","volume":"128","author":"Cianci","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00128071-200304010-00002","article-title":"Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists","volume":"4","author":"Collin","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01310.x-BIB60","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3945\/ajcn.2008.26427","article-title":"Weight loss makes obese patients with moderate to severe chronic plaque psoriasis highly responsive to low dose cyclosporine: a randomized, controlled, investigator blinded, clinical trial","volume":"88","author":"Gisondi","year":"2008","journal-title":"Am J Clin Nutr"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2010.01310.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2010.01310.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:21:11Z","timestamp":1739989271000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2010.01310.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2010.01310.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}